| 000009 (2021) |
Rashed Noor [Bangladesh] | Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic. |
| 001349 (2020) |
Ruanne V. Barnabas [États-Unis] ; Elizabeth Brown [États-Unis] ; Anna Bershteyn [États-Unis] ; R Scott Miller [États-Unis] ; Mark Wener [États-Unis] ; Connie Celum [États-Unis] ; Anna Wald [États-Unis] ; Helen Chu [États-Unis] ; David Wesche [États-Unis] ; Jared M. Baeten [États-Unis] | Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. |
| 000110 (2021) |
Consolato M. Sergi [Canada] ; Brian Chiu [Canada] | Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
| 000396 (2021) |
Agata Blasiak ; Jhin Jieh Lim ; Shirley Gek Kheng Seah ; Theodore Kee ; Alexandria Remus ; De Hoe Chye ; Pui San Wong ; Lissa Hooi ; Anh T L. Truong ; Nguyen Le ; Conrad E Z. Chan ; Rishi Desai ; Xianting Ding ; Brendon J. Hanson ; Edward Kai-Hua Chow ; Dean Ho | IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. |
| 000740 (2021) |
Viktorija Dragojevic Simic [Serbie] ; Milijana Miljkovic [Serbie] ; Dusica Stamenkovic [Serbie] ; Berislav Vekic [Serbie] ; Nenad Ratkovic [Serbie] ; Radoje Simic [Serbie] ; Nemanja Rancic [Serbie] | An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine. |
| 000753 (2021) |
Viral D. Patel [Inde] ; Khushbu H. Patel [États-Unis] ; Dhairya A. Lakhani [États-Unis] ; Rupak Desai [États-Unis] ; Deep Mehta [États-Unis] ; Priyank Mody [Inde] ; Sumit Pruthi [États-Unis] | Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations. |
| 000F05 (2020) |
Y C Tsai [Taïwan] ; T F Tsai [Taïwan] | Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review. |
| 001551 (2020) |
Simone Piva [Italie] ; Matteo Filippini [Italie] ; Fabio Turla [Italie] ; Sergio Cattaneo [Italie] ; Alessio Margola [Italie] ; Silvia De Fulviis [Italie] ; Ida Nardiello [Italie] ; Alessandra Beretta [Italie] ; Laura Ferrari [Italie] ; Raffaella Trotta [Italie] ; Gloria Erbici [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Frank Rasulo [Italie] ; Michael J. Lanspa [États-Unis] ; Nicola Latronico [Italie] | Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. |
| 001888 (2020) |
Su-Jin Park [Corée du Sud] ; Kwang-Min Yu [Corée du Sud] ; Young-Il Kim [Corée du Sud] ; Se-Mi Kim [Corée du Sud] ; Eun-Ha Kim [Corée du Sud] ; Seong-Gyu Kim [Corée du Sud] ; Eun Ji Kim [Corée du Sud] ; Mark Anthony B. Casel [Corée du Sud] ; Rare Rollon [Corée du Sud] ; Seung-Gyu Jang [Corée du Sud] ; Min-Hyeok Lee [Corée du Sud] ; Jae-Hyung Chang [Corée du Sud] ; Min-Suk Song [Corée du Sud] ; Hye Won Jeong [Corée du Sud] ; Younho Choi [États-Unis] ; Weiqiang Chen [États-Unis] ; Woo-Jin Shin [États-Unis] ; Jae U. Jung [États-Unis] ; Young Ki Choi [États-Unis, Corée du Sud] | Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets. |
| 001978 (2020) |
Teodoro J. Oscanoa [Pérou] ; Roman Romero-Ortuno [Irlande (pays)] ; Alfonso Carvajal [Espagne] ; Andrea Savarino [Italie] | A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? |
| 000084 (2021) |
Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis] | The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review. |
| 000086 (2021) |
Gerard Espinosa [Espagne] ; Sergio Prieto-González [Espagne] ; Mireia Llevadot [Espagne] ; Javier Marco-Hernández [Espagne] ; Antonio Martínez-Artu A [Espagne] ; Albert Pérez-Isidro [Espagne] ; Elia Rifé [Espagne] ; Ricard Cervera [Espagne] | The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia. |
| 000114 (2021) |
Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis] | Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. |
| 000146 (2021) |
Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil Kuca | Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics. |
| 000175 (2021) |
Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen Sliwa | SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications. |
| 000273 (2021) |
Luis Enrique Bermejo Galan [Brésil] ; Nayara Melo Dos Santos ; Mauro Shosuka Asato ; Jucineide Vieira Araújo [Brésil] ; Adriana De Lima Moreira [Brésil] ; Aléxia Mahara Marques Araújo [Brésil] ; Artur Diogenes Pinheiro Paiva [Brésil] ; Diego Guilherme Santos Portella [Brésil] ; Frank Silas Saldanha Marques [Brésil] ; Gabriel Melo Alexandre Silva [Brésil] ; Joana De Sousa Resende [Brésil] ; Marycassiely Rodrigues Tizolim [Brésil] ; Poliana Lucenados Santos [Brésil] ; Steffi Ferreira Buttenbender [Brésil] ; Stephanye Batista De Andrade [Brésil] ; Roberto Carlos Cruz Carbonell [Brésil] ; Juliana Gomes Da Rocha ; Ruy Guilherme Silveira De Souza [Brésil] ; Allex Jardim Da Fonseca [Brésil] | Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection. |
| 000341 (2021) |
Kaho Shionoya [Japon] ; Masako Yamasaki [Japon] ; Shoya Iwanami [Japon] ; Yusuke Ito [Japon] ; Shuetsu Fukushi [Japon] ; Hirofumi Ohashi [Japon] ; Wakana Saso [Japon] ; Tomohiro Tanaka [Japon] ; Shin Aoki [Japon] ; Kouji Kuramochi [Japon] ; Shingo Iwami [Japon] ; Yoshimasa Takahashi [Japon] ; Tadaki Suzuki [Japon] ; Masamichi Muramatsu [Japon] ; Makoto Takeda [Japon] ; Takaji Wakita [Japon] ; Koichi Watashi [Japon] | Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. |
| 000372 (2021) |
Jyoti Choudhary [Inde] ; Shrivardhan Dheeman [Inde] ; Vipin Sharma [Inde] ; Prashant Katiyar [Inde] ; Santosh Kumar Karn [Inde] ; Manoj Kumar Sarangi [Inde] ; Ankit Kumar Chauhan [Inde] ; Gaurav Verma [Inde] ; Nitin Baliyan [Inde] | Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review. |
| 000379 (2021) |
Ivan Guerra [Espagne] ; Alicia Algaba [Espagne] ; Laura Jiménez [Espagne] ; M. Mar Aller [Espagne] ; Daniel Garza [Espagne] ; Daniel Bonillo [Espagne] ; Laura María Molina Esteban [Espagne] ; Fernando Bermejo [Espagne] | Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. |
| 000389 (2021) |
Nirvana Awad [États-Unis] ; Daryl S. Schiller [États-Unis] ; Magda Fulman [États-Unis] ; Azfar Chak [États-Unis] | Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection. |
| 000522 (2021) |
Jogender Kumar [Inde] ; Siddharth Jain [Inde] ; Jitendra Meena [Inde] ; Arushi Yadav [Inde] | Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis. |
| 000533 (2021) |
Annoor Awadasseid [Soudan] ; Yanling Wu [République populaire de Chine] ; Yoshimasa Tanaka [Japon] ; Wen Zhang [République populaire de Chine] | Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines. |
| 000538 (2021) |
Sun-Young Jung [Corée du Sud] ; Myo-Song Kim [Corée du Sud] ; Min-Chul Kim [Corée du Sud] ; Seong-Ho Choi [Corée du Sud] ; Jin-Won Chung [Corée du Sud] ; Sang Tae Choi [Corée du Sud] | Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study. |
| 000550 (2021) |
Markus Blaess [Allemagne] ; Lars Kaiser [Allemagne] ; Oliver Sommerfeld [Allemagne] ; René Csuk [Allemagne] ; Hans-Peter Deigner [Allemagne] | Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. |
| 000565 (2021) |
Iwein Gyselinck [Belgique] ; Laurens Liesenborghs [Belgique] ; Ewout Landeloos [Belgique] ; Ann Belmans [Belgique] ; Geert Verbeke [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] ; W. Janssens [Belgique] | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. |
| 000620 (2021) |
Alessandro Lucchesi [Italie] ; Paolo Silimbani [Italie] ; Gerardo Musuraca [Italie] ; Claudio Cerchione [Italie] ; Giovanni Martinelli [Italie] ; Paola Di Carlo [Italie] ; Mariasanta Napolitano [Italie] | Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease. |
| 000774 (2021) |
Arif Kivrak [Turquie] ; Berdan Ula [Turquie] ; Hilal Kivrak [Turquie] | A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2. |
| 000826 (2020) |
M J Abenza Abildúa [Espagne] ; M T Ramírez Prieto [Espagne] ; R. Moreno Zabaleta [Espagne] ; C. Algarra Lucas [Espagne] ; C. Pérez L Pez [Espagne] | [Myopathy associated with severe SARS-CoV-2 infection]. |
| 000851 (2020) |
P. Conti [Italie] ; A. Younes [Italie] | Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. |
| 000853 (2020) |
Vidya M. Mahalmani [Inde] ; Dhruv Mahendru [Inde] ; Phulen Sarma [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde] | Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown. |
| 000920 (2020) |
Áurea Redondo-Sendino [Espagne] ; Isabel Cristina González Sánchez [Espagne] ; Beatriz De Victoria Fernández [Espagne] | [Skin manifestations associated with the new coronavirus SARS-CoV-2 disease]. |
| 000921 (2020) |
Saadia Ait Malek [Maroc] ; Imane El Bouchti [Maroc] | [SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease]. |
| 000970 (2020) |
Sudhir Mehta [Inde] ; Sudhir Bhandari [Inde] ; Shaurya Mehta [Inde] | Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection? |
| 000980 (2020) |
Brian Lipworth [Royaume-Uni] ; Rory Chan [Royaume-Uni] ; Samuel Lipworth [Royaume-Uni] ; Chris Ruiwen Kuo [Royaume-Uni] | Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection. |
| 000A05 (2020) |
Frederic Sacher [France] ; Laurent Fauchier [France] ; Serge Boveda [France] ; Christian De Chillou [France] ; Pascal Defaye [France] ; Jean Claude Deharo [France] ; Estelle Gandjbakhch [France] ; Vincent Probst [France] ; Ariel Cohen [France] ; Christophe Leclercq [France] | Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection. |
| 000A72 (2020) |
Mohammad Nasir Uddin ; Md Shaharier Amin ; Md Saifur Rahman ; Sonia Khandaker ; Wahhida Shumi ; Md Atiar Rahman ; Sheikh Mahbubur Rahman | Titanium (IV) complexes of some tetra-dentate symmetrical bis-Schiff bases of 1,6-hexanediamine: Synthesis, characterization, and in silico prediction of potential inhibitor against coronavirus (SARS-CoV-2). |
| 000A82 (2020) |
Sachin Khunti [Royaume-Uni] ; Nitisha Khunti [Royaume-Uni] ; Samuel Seidu [Royaume-Uni] ; Kamlesh Khunti [Royaume-Uni] | Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). |
| 000A96 (2020) |
Wen Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Fengchun Zhang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine] | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. |
| 000B03 (2020) |
Eugenia Quiros Roldan [Italie] ; Giorgio Biasiotto [Italie] ; Paola Magro [Italie] ; Isabella Zanella [Italie] | The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? |
| 000B23 (2020) |
Kuma Diriba [Éthiopie] ; Ephrem Awulachew [Éthiopie] ; Eyob Getu [Éthiopie] | The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. |
| 000B98 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000C52 (2020) |
Michele Costanzo [Italie] ; Maria Anna Rachele De Giglio [Italie] ; Giovanni Nicola Roviello [Italie] | SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. |
| 000C68 (2020) |
Alexandre Carvalho [États-Unis] ; Rana Alqusairi [États-Unis] ; Anna Adams [États-Unis] ; Michelle Paul [États-Unis] ; Neelay Kothari [États-Unis] ; Stevany Peters [États-Unis] ; Anthony T. Debenedet [États-Unis] | SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. |
| 000D14 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al. |
| 000D58 (2020) |
Tarek Mohamed Abd El-Aziz [Égypte] ; James D. Stockand [États-Unis] | Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. |
| 000E44 (2020) |
Sylvain A. Lother [Canada] ; Mahsa Abassi [États-Unis] ; Alyssa Agostinis [Canada, Irlande (pays)] ; Ananta S. Bangdiwala [États-Unis] ; Matthew P. Cheng [Canada] ; Glen Drobot [Canada] ; Nicole Engen [États-Unis] ; Kathy H. Hullsiek [États-Unis] ; Lauren E. Kelly [Canada] ; Todd C. Lee [Canada] ; Sarah M. Lofgren [États-Unis] ; Lauren J. Mackenzie [Canada] ; Nicole Marten [Canada] ; Emily G. Mcdonald [Canada] ; Elizabeth C. Okafor [États-Unis] ; Katelyn A. Pastick [États-Unis] ; Matthew F. Pullen [États-Unis] ; Radha Rajasingham [États-Unis] ; Ilan Schwartz [Canada] ; Caleb P. Skipper [États-Unis] ; Alexis F. Turgeon [Canada] ; Ryan Zarychanski [Canada] ; David R. Boulware [États-Unis] | Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. |
| 000E76 (2020) |
Kiran Gajurel [États-Unis] | Persistently positive severe acute respiratory syndrome coronavirus 2 (SARS-COV2) nasopharyngeal PCR in a kidney transplant recipient. |
| 000F68 (2020) |
Ahmad F. Eweas [Égypte, Oman] ; Amr A. Alhossary [Singapour] ; Ahmed S. Abdel-Moneim [Arabie saoudite] | Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2. |
| 001073 (2020) |
Helyson Lucas Bezerra Braz [Brésil] ; João Alison De Moraes Silveira [Brésil] ; Aline Diogo Marinho [Brésil] ; Maria Elisabete Amaral De Moraes [Brésil] ; Manoel Odorico De Moraes Filho [Brésil] ; Helena Serra Azul Monteiro [Brésil] ; Roberta Jeane Bezerra Jorge [Brésil] | In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. |
| 001082 (2020) |
Xueting Yao [République populaire de Chine] ; Fei Ye [République populaire de Chine] ; Miao Zhang [République populaire de Chine] ; Cheng Cui [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Peihua Niu [République populaire de Chine] ; Xu Liu [République populaire de Chine] ; Li Zhao [République populaire de Chine] ; Erdan Dong [République populaire de Chine] ; Chunli Song [République populaire de Chine] ; Siyan Zhan [République populaire de Chine] ; Roujian Lu [République populaire de Chine] ; Haiyan Li [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Dongyang Liu [République populaire de Chine] | In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
| 001083 (2020) |
Pablo Zubiaur [Espagne] ; Dora Koller [Espagne] ; Miriam Saiz-Rodríguez [Espagne] ; Marcos Navares-G Mez [Espagne] ; Francisco Abad-Santos [Espagne] | Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). |
| 001086 (2020) |
Changsong Lin [République populaire de Chine] ; Ziyu Wang [République populaire de Chine] ; Jie Li [République populaire de Chine] ; Xinyi Xia [République populaire de Chine] ; Yun Liu [République populaire de Chine] ; Qianghu Wang [République populaire de Chine] | Implications of SARS-CoV-2 infection for patients with rheumatic disease. |
| 001149 (2020) |
Pauline Maisonnasse [France] ; Jérémie Guedj [France] ; Vanessa Contreras [France] ; Sylvie Behillil [France] ; Caroline Solas [France] ; Romain Marlin [France] ; Thibaut Naninck [France] ; Andres Pizzorno [France] ; Julien Lemaitre [France] ; Antonio Gonçalves [France] ; Nidhal Kahlaoui [France] ; Olivier Terrier [France] ; Raphael Ho Tsong Fang [France] ; Vincent Enouf [France] ; Nathalie Dereuddre-Bosquet [France] ; Angela Brisebarre [France] ; Franck Touret [France] ; Catherine Chapon [France] ; Bruno Hoen [France] ; Bruno Lina [France] ; Manuel Rosa Calatrava [France] ; Sylvie Van Der Werf [France] ; Xavier De Lamballerie [France] ; Roger Le Grand [France] | Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. |
| 001195 (2020) |
Raquel González [Espagne, Mozambique] ; Laura García-Otero [Espagne, Mozambique] ; Clara Pons-Duran [Espagne] ; Elena Marbán-Castro [Espagne] ; Anna Goncé [Espagne] ; Elisa Llurba [Espagne] ; Maria Del Mar Gil [Espagne] ; Miguel Ngel Rodríguez-Zambrano [Espagne] ; Haily Chen [Espagne] ; Máximo Ramírez [Espagne] ; Azucena Bardají [Espagne, Mozambique] ; Clara Menendez [Espagne, Mozambique] | Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial. |
| 001201 (2020) |
A. Klimke [Allemagne] ; G. Hefner [Allemagne] ; B. Will [Allemagne] ; U. Voss [Allemagne] | Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection. |
| 001203 (2020) |
Virgilio Galvis [Colombie] ; Francesca Romana Spinelli [Italie] ; Alejandro Tello [Colombie] ; Claudia L. Sossa [Colombie] ; Juan D. Higuera [Colombie] ; Edgar D. G Mez [Colombie] ; Sergio E. Serrano [Colombie] ; Paul A. Camacho [Colombie] ; Federico G. Velez [États-Unis] | Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials. |
| 001204 (2020) |
Virgilio Galvis [Colombie] ; Francesca Romana Spinelli [Italie] ; Alejandro Tello [Colombie] ; Claudia L. Sossa [Colombie] ; Juan D. Higuera [Colombie] ; Edgar D. G Mez [Colombie] ; Sergio E. Serrano [Colombie] ; Paul A. Camacho [Colombie] ; Federico G. Velez [États-Unis] | Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials. |
| 001255 (2020) |
Elizabeth Delorme-Axford [États-Unis] ; Daniel J. Klionsky [États-Unis] | Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? |
| 001406 (2020) |
Fabricio S. Neves [Brésil] | Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection. |
| 001448 (2020) |
Zai-Li Zhang [République populaire de Chine] ; Han Zhong [République populaire de Chine] ; Yang-Xi Liu [République populaire de Chine] ; Ke-Jia Le [République populaire de Chine] ; Min Cui [République populaire de Chine] ; Yue-Tian Yu [République populaire de Chine] ; Zhi-Chun Gu [République populaire de Chine] ; Yuan Gao [République populaire de Chine] ; Hou-Wen Lin [République populaire de Chine] | Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol. |
| 001541 (2020) |
Emilie Sbidian [France] ; Laetitia Penso [France] ; Philippe Herlemont [France] ; Jérémie Botton [France] ; Bérangère Baricault [France] ; Laura Semenzato [France] ; Jérome Drouin [France] ; Alain Weill [France] ; Rosemay Dray-Spira [France] ; Mahmoud Zureik [France] | Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France. |
| 001688 (2020) |
Dwight L. Mckee [États-Unis] ; Ariane Sternberg [Allemagne] ; Ulrike Stange [Allemagne] ; Stefan Laufer [Allemagne] ; Cord Naujokat [Allemagne] | Candidate drugs against SARS-CoV-2 and COVID-19. |
| 001710 (2020) |
Giuseppe Magro [Italie] | COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking. |
| 001843 (2020) |
Maximilian F. Konig [États-Unis] ; Alfred Hj Kim [États-Unis] ; Marc H. Scheetz [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Jean W. Liew [États-Unis] ; Julia Simard [États-Unis] ; Pedro M. Machado [Royaume-Uni] ; Milena Gianfrancesco [États-Unis] ; Jinoos Yazdany [États-Unis] ; Daman Langguth [Australie] ; Philip C. Robinson [États-Unis] | Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. |
| 001887 (2020) |
Seong Woo Choi [Corée du Sud] ; Jin Soo Shin [Corée du Sud] ; Soon-Jung Park [Corée du Sud] ; Eunhye Jung [Corée du Sud] ; Yun-Gwi Park [Corée du Sud] ; Jiho Lee [Corée du Sud] ; Sung Joon Kim [Corée du Sud] ; Hun-Jun Park [Corée du Sud] ; Jung-Hoon Lee [République populaire de Chine] ; Sung-Min Park [Corée du Sud] ; Sung-Hwan Moon [Corée du Sud] ; Kiwon Ban [République populaire de Chine] ; Yun Young Go [République populaire de Chine] | Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. |
| 001898 (2020) |
Eleftherios Pelechas [Grèce] ; Vassiliki Drossou [Grèce] ; Paraskevi V. Voulgari [Grèce] ; Alexandros A. Drosos [Grèce] | Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence? |
| 001A05 (2020) |
Serban C. Musca [France] | A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2. |
| 000038 (2021) |
María Antonela Zígolo [Argentine] ; Matías Rivero Goytia [Argentine] ; Hugo Ramiro Poma [Argentine] ; Ver Nica Beatriz Rajal [Singapour] ; Ver Nica Patricia Irazusta [Argentine] | Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. |
| 000039 (2021) |
Roland Duculan ; Deanna Jannat-Khah ; Bella Mehta ; Lisa A. Mandl ; Medha Barbhaiya ; Anne R. Bass ; Carol A. Mancuso | Variables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases. |
| 000049 (2021) |
Boghuma K. Titanji [États-Unis] ; Monica M. Farley [États-Unis] ; Ashish Mehta [États-Unis] ; Randi Connor-Schuler [États-Unis] ; Abeer Moanna [États-Unis] ; Sushma K. Cribbs [États-Unis] ; Jesse O'Shea [États-Unis] ; Kathryn Desilva [États-Unis] ; Bonnie Chan [États-Unis] ; Alex Edwards [États-Unis] ; Christina Gavegnano [États-Unis] ; Raymond F. Schinazi [États-Unis] ; Vincent C. Marconi [États-Unis] | Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019. |
| 000058 (2021) |
George N. Ioannou [États-Unis] ; Ann M. O'Hare [États-Unis] ; Kristin Berry [États-Unis] ; Vincent S. Fan [États-Unis] ; Kristina Crothers [États-Unis] ; Mckenna C. Eastment [États-Unis] ; Emily Locke [États-Unis] ; Pamela Green [États-Unis] ; Javeed A. Shah [États-Unis] ; Jason A. Dominitz [États-Unis] | Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection. |
| 000070 (2021) |
Bagrat Lalabekyan [Royaume-Uni] ; Gudrun Kunst [Royaume-Uni] ; Vanessa A. Skelton [Royaume-Uni] | Torsades de Pointes in Coronavirus Disease 2019 Infection. |
| 000094 (2021) |
Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde] | The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review. |
| 000098 (2021) |
Antonio Desai [Italie] ; Giuseppe Caltagirone [Italie] ; Sharon Sari [Italie] ; Daria Pocaterra [Italie] ; Maria Kogan [Italie] ; Elena Azzolini [Italie] ; Victor Savevski [Italie] ; Filippo Martinelli-Boneschi [Italie] ; Antonio Voza [Italie] ; On Behalf Of The Humanitas Covid-Task Force [Italie] | The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults. |
| 000117 (2021) |
Tesia Bobrowski [États-Unis] ; Lu Chen [États-Unis] ; Richard T. Eastman [États-Unis] ; Zina Itkin [États-Unis] ; Paul Shinn [États-Unis] ; Catherine Z. Chen [États-Unis] ; Hui Guo [États-Unis] ; Wei Zheng [États-Unis] ; Sam Michael [États-Unis] ; Anton Simeonov [États-Unis] ; Matthew D. Hall [États-Unis] ; Alexey V. Zakharov [États-Unis] ; Eugene N. Muratov [États-Unis] | Synergistic and Antagonistic Drug Combinations against SARS-CoV-2. |
| 000121 (2021) |
| Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection. |
| 000128 (2021) |
Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud] | Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. |
| 000129 (2021) |
Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde] | Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies. |
| 000155 (2021) |
Alberto Enrico Maraolo [Italie] ; Adriano Grossi [Italie] | Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials. |
| 000159 (2021) |
Masoud Solaymani-Dodaran [Iran] ; Mostafa Ghanei [Iran] ; Mehdi Bagheri [Iran] ; Ali Qazvini [Iran] ; Ensieh Vahedi [Iran] ; Seyed Hassan Saadat [Iran] ; Seyed Amin Setarehdan [Iran] ; Akram Ansarifar [Iran] ; Hossein Biganeh [Iran] ; Arash Mohazzab [Iran] ; Davood Khalili [Iran] ; Amir Hosein Ghazale [Iran] ; Mohammad Reza Heidari [Iran] ; Ali Taheri [Iran] ; Maliheh Khoramdad [Iran] ; Mohammad Mahdi Asadi [Iran] ; Masoud Nazemieh [Iran] ; Mojtaba Varshochi [Iran] ; Samaneh Abbasian [Iran] ; Ali Bakhtiari [Iran] ; Reza Mosaed [Iran] ; Seyyed-Javad Hosseini-Shokouh [Iran] ; Masoume Shahrokhi [Iran] ; Zeynab Yassin [Iran] ; Mohammad Ali Zohal [Iran] ; Maryam Qaraati [Iran] ; Nafiseh Rastgoo [Iran] ; Ramin Sami [Iran] ; Mohammad Javad Eslami [Iran] ; Akram Asghari [Iran] ; Mansoor Namazi [Iran] ; Shadi Ziaie [Iran] ; Raana Jafari-Moghaddam [Iran] ; Saeid Kalantari [Iran] ; Mohammad Memarian [Iran] ; Javad Khodadadi [Iran] ; Mohammad Hossein Afshari [Iran] ; Mansooreh Momen-Heravi [Iran] ; Niusha Behzadseresht [Iran] ; Ahmad Reza Mobayen [Iran] ; Abolfazl Mozafari [Iran] ; Fatemeh Movasaghi [Iran] ; Maryam Haddadzadeh Shoushtari [Iran] ; Javad Moazen [Iran] | Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. |
| 000163 (2021) |
Tanvir Rahman [États-Unis] ; Quazim A. Alayo [États-Unis] ; Sibgha G. Chaudhary [États-Unis] ; Reihaneh C. Moghadam [États-Unis] ; Matthew L. German [États-Unis] ; Neil A. Ettinger [États-Unis] ; Jeremy E. Leidenfrost [États-Unis] ; Hope A. Cranston-D'Amato [États-Unis] ; Morton R. Rinder [États-Unis] ; Julianne E. Donnelly [États-Unis] | STEMI associated with SARS-CoV-2 infection and the use of ECMO as a potential therapeutic approach in addition to the PCI. |
| 000169 (2021) |
Bianca D. Balmant [Brésil] ; Raquel S. Torrinhas [Brésil] ; Ilanna M. Rocha [Brésil] ; Danielle C. Fonseca [Brésil] ; Francisco F C. Formiga [Brésil] ; Eloisa S D O. Bonfá [Brésil] ; Eduardo F. Borba [Brésil] ; Dan L. Waitzberg [Brésil] | SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? |
| 000170 (2021) |
Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal] | SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases. |
| 000171 (2021) |
Carmen Manciuc [Roumanie] ; Dragos Nemescu [Roumanie] ; Andrei Vata [Roumanie] ; Georgiana Alexandra Lacatusu [Roumanie] | SARS-CoV-2 infection and diabetes mellitus: A North Eastern Romanian experience. |
| 000177 (2021) |
Kevin L. Winthrop [États-Unis] ; Amanda E. Brunton [États-Unis] ; Susan Beekmann [États-Unis] ; Philip Polgreen [États-Unis] ; John Baddley [États-Unis] ; Kenneth G. Saag [États-Unis] ; Cassandra Calabrese [États-Unis] ; Leonard Calabrese [États-Unis] ; Philip C. Robinson [Australie] ; Zachary S. Wallace [États-Unis] ; Jeffrey R. Curtis [États-Unis] | SARS CoV-2 infection among patients using immunomodulatory therapies. |
| 000179 (2021) |
Priyamadhaba Behera [Inde] ; Binod Kumar Patro [Inde] ; Arvind Kumar Singh [Inde] ; Pradnya Dilip Chandanshive [Inde] ; Ravikumar S R [Inde] ; Somen Kumar Pradhan [Inde] ; Siva Santosh Kumar Pentapati [Inde] ; Gitanjali Batmanabane [Inde] ; Prasanta Raghab Mohapatra [Inde] ; Biswa Mohan Padhy [Inde] ; Shakti Kumar Bal [Inde] ; Sudipta Ranjan Singh [Inde] ; Rashmi Ranjan Mohanty [Inde] | Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study. |
| 000191 (2021) |
Dhruva Sharma [Inde] ; Neha Sharma [Inde] ; Preksha Sharma [Inde] ; Ganapathy Subramaniam [Inde] | Review of investigational drugs for coronavirus disease 2019. |
| 000197 (2021) |
Paolo Agostinis [Italie] ; Valentina Vianello [Italie] ; Elena Dereani [Italie] ; Giuseppe Caruso [Italie] ; Beatrice Montessoro [Italie] ; Marco Taurian [Italie] ; Antonio Di Chiara [Italie] ; Vincenzo Patruno [Italie] ; Francesco Cavallin [Italie] ; Gian Paolo Fadini [Italie] ; Anna Aldovini [États-Unis] ; Anna Baritussio [Italie] ; Francesco Curcio [Italie] ; Carlo Tascini [Italie] ; Aldo Baritussio [Italie] | Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center. |
| 000199 (2021) |
Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie] | Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al. |
| 000203 (2021) |
F O Shode [Afrique du Sud] ; A S K. Idowu [Afrique du Sud] ; O J Uhomoibhi [Afrique du Sud] ; S. Sabiu [Afrique du Sud] | Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. |
| 000204 (2021) |
Evellyn Claudia Wietzikoski Lovato [Brésil] ; Lorena Neris Barboza [Brésil] ; Samantha Wietzikoski [Brésil] ; Amanda Nascimento Vasques De Souza [Brésil] ; Pablo Alvarez Auth [Brésil] ; Arquimedes Gasparotto Junior [Brésil] ; Francislaine Aparecida Dos Reis Lívero [Brésil] | Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19). |
| 000232 (2021) |
Maximilian Gro E [Allemagne] ; Natalia Ruetalo [Allemagne] ; Mirjam Layer [Allemagne] ; Dan Hu [Allemagne] ; Ramona Businger [Allemagne] ; Sascha Rheber [Allemagne] ; Christian Setz [Allemagne] ; Pia Rauch [Allemagne] ; Janina Auth [Allemagne] ; Maria Fröba [Allemagne] ; Ekkehard Brysch [Allemagne] ; Michael Schindler [Allemagne] ; Ulrich Schubert [Allemagne] | Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. |
| 000264 (2021) |
Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine] | Potential inhibitors for the novel coronavirus (SARS-CoV-2). |
| 000282 (2021) |
Daniele Di Mascio [Italie] ; Francesco D'Antonio [Italie] | Perinatal mortality and morbidity of SARS-COV-2 infection during pregnancy in European countries: Findings from an international study. |
| 000306 (2021) |
Pobitra Borah [Inde] ; Pran Kishore Deb [Jordanie] ; Balakumar Chandrasekaran [Jordanie] ; Manoj Goyal [Arabie saoudite] ; Monika Bansal [Arabie saoudite] ; Snawar Hussain [Arabie saoudite] ; Pottathil Shinu [Arabie saoudite] ; Katharigatta N. Venugopala [Afrique du Sud] ; Nizar A. Al-Shar'I [Jordanie] ; Satyendra Deka [Inde] ; Vinayak Singh [Afrique du Sud] | Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. |
| 000307 (2021) |
Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde] | Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. |
| 000319 (2021) |
Kathleen Chiotos [États-Unis] ; Molly Hayes [États-Unis] ; David W. Kimberlin [États-Unis] ; Sarah B. Jones [États-Unis] ; Scott H. James [États-Unis] ; Swetha G. Pinninti [États-Unis] ; April Yarbrough [États-Unis] ; Mark J. Abzug [États-Unis] ; Christine E. Macbrayne [États-Unis] ; Vijaya L. Soma [États-Unis] ; Daniel E. Dulek [États-Unis] ; Surabhi B. Vora [États-Unis] ; Alpana Waghmare [États-Unis] ; Joshua Wolf [États-Unis] ; Rosemary Olivero [États-Unis] ; Steven Grapentine [États-Unis] ; Rachel L. Wattier [États-Unis] ; Laura Bio [États-Unis] ; Shane J. Cross [États-Unis] ; Nicholas O. Dillman [États-Unis] ; Kevin J. Downes [États-Unis] ; Carlos R. Oliveira [États-Unis] ; Kathryn Timberlake [Canada] ; Jennifer Young [États-Unis] ; Rachel C. Orscheln [États-Unis] ; Pranita D. Tamma [États-Unis] ; Hayden T. Schwenk [États-Unis] ; Philip Zachariah [États-Unis] ; Margaret L. Aldrich [États-Unis] ; David L. Goldman [États-Unis] ; Helen E. Groves [Canada] ; Nipunie S. Rajapakse [États-Unis] ; Gabriella S. Lamb [États-Unis] ; Alison C. Tribble [États-Unis] ; Adam L. Hersh [États-Unis] ; Emily A. Thorell [États-Unis] ; Mark R. Denison [États-Unis] ; Adam J. Ratner [États-Unis] ; Jason G. Newland [États-Unis] ; Mari M. Nakamura [États-Unis] | Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. |
| 000330 (2021) |
Himanshu Rai [Inde] ; Atanu Barik [Inde] ; Yash Pal Singh [Inde] ; Akhil Suresh [Inde] ; Lovejit Singh [Inde] ; Gourav Singh [Inde] ; Usha Yogendra Nayak [Inde] ; Vikash Kumar Dubey [Inde] ; Gyan Modi [Inde] | Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19. |
| 000349 (2021) |
Gaber El-Saber Batiha [Égypte] ; Marwa A. Zayed [Égypte] ; Aya A. Awad [Égypte] ; Hazem M. Shaheen [Égypte] ; Suleiman Mustapha [Nigeria] ; Oscar Herrera-Calderon [Pérou] ; Jorge Pamplona Pagnossa [Brésil] ; Abdelazeem M. Algammal [Égypte] ; Muhammad Zahoor [Pakistan] ; Achyut Adhikari [Népal] ; Ishan Pandey [Inde] ; Sara T. Elazab [Égypte] ; Kannan R R. Rengasamy [Afrique du Sud] ; Natália Cruz-Martins [Portugal] ; Helal F. Hetta [Égypte] | Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19. |
| 000360 (2021) |
Sergey Moiseev [Oman] ; Sergey Avdeev [Russie] ; Michail Brovko [Russie] ; Pavel Novikov [Russie] ; Victor Fomin [Russie] | Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? |
